CYP1A1 and non-small cell lung carcinoma: The levels of p-Akt in human serum were examined using a clinical sample set, which included serum samples from eight normal control subjects, eight patients with NSCLC without CYP1A1 overediting, and eight patients with NSCLC with CYP1A1 overediting for confirmation.